Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saik Urien

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
BMC Pharmacology & Toxicology|August 7, 2013
Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromesSaik Urien, Christophe Bardin, Brigitte Bader-Meunier, et al.
The Journal of Antimicrobial Chemotherapy|August 7, 2021
Ciprofloxacin population pharmacokinetics during long-term treatment of osteoarticular infectionsNoël Zahr, Saik Urien, Alexandra Aubry, et al.
Pharmaceutics|December 23, 2022
Total and Unbound Pharmacokinetics of Cefiderocol in Critically Ill PatientsNoël Zahr, Saik Urien, Benoit Llopis, et al.
Cancer Chemotherapy and Pharmacology|May 22, 2010
Developmental pharmacokinetics of etoposide in 67 children: lack of dexamethasone effectSaik Urien, François Doz, Carole Giraud, et al.
American Journal of Clinical Oncology|June 1, 2004
Oxaliplatin plus irinotecan and FU-FOL combination and pharmacokinetic analysis in advanced colorectal cancer patientsMarian A Gil-Delgado, Gerard Bastian, François Guinet, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 18, 2024
Impact of pediatric continuous renal replacement therapy parameters on meropenem, piperacillin, and tazobactam pharmacokinetics: an <i>in vitro</i> modelMichael Thy, Floura Kecili, Saik Urien, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2009
Is the recommended dose of efavirenz optimal in young West African human immunodeficiency virus-infected children?Déborah Hirt, Saik Urien, Mathieu Olivier, et al.
Clinical Pharmacokinetics|October 22, 2016
A Physiologically-Based Pharmacokinetic Model to Predict Human Fetal Exposure for a Drug Metabolized by Several CYP450 PathwaysMaïlys De Sousa Mendes, Gabrielle Lui, Yi Zheng, et al.
Molecular Imaging and Biology|December 4, 2015
Multimodal In Vivo Imaging of Tumorigenesis and Response to Chemotherapy in a Transgenic Mouse Model of Mammary CancerJean-Louis Alberini, Raphaël Boisgard, Stéphanie Guillermet, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 24, 2010
A phase I trial combining oral cisplatin (CP Ethypharm) with radiotherapy in patients with locally advanced head and neck squamous cell carcinomaYungan Tao, Keyvan Rezaï, Etienne Brain, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
BMC Pharmacology & Toxicology|August 7, 2013
Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromesSaik Urien, Christophe Bardin, Brigitte Bader-Meunier, et al.
The Journal of Antimicrobial Chemotherapy|August 7, 2021
Ciprofloxacin population pharmacokinetics during long-term treatment of osteoarticular infectionsNoël Zahr, Saik Urien, Alexandra Aubry, et al.
Pharmaceutics|December 23, 2022
Total and Unbound Pharmacokinetics of Cefiderocol in Critically Ill PatientsNoël Zahr, Saik Urien, Benoit Llopis, et al.
Cancer Chemotherapy and Pharmacology|May 22, 2010
Developmental pharmacokinetics of etoposide in 67 children: lack of dexamethasone effectSaik Urien, François Doz, Carole Giraud, et al.
American Journal of Clinical Oncology|June 1, 2004
Oxaliplatin plus irinotecan and FU-FOL combination and pharmacokinetic analysis in advanced colorectal cancer patientsMarian A Gil-Delgado, Gerard Bastian, François Guinet, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 18, 2024
Impact of pediatric continuous renal replacement therapy parameters on meropenem, piperacillin, and tazobactam pharmacokinetics: an <i>in vitro</i> modelMichael Thy, Floura Kecili, Saik Urien, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2009
Is the recommended dose of efavirenz optimal in young West African human immunodeficiency virus-infected children?Déborah Hirt, Saik Urien, Mathieu Olivier, et al.
Clinical Pharmacokinetics|October 22, 2016
A Physiologically-Based Pharmacokinetic Model to Predict Human Fetal Exposure for a Drug Metabolized by Several CYP450 PathwaysMaïlys De Sousa Mendes, Gabrielle Lui, Yi Zheng, et al.
Molecular Imaging and Biology|December 4, 2015
Multimodal In Vivo Imaging of Tumorigenesis and Response to Chemotherapy in a Transgenic Mouse Model of Mammary CancerJean-Louis Alberini, Raphaël Boisgard, Stéphanie Guillermet, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 24, 2010
A phase I trial combining oral cisplatin (CP Ethypharm) with radiotherapy in patients with locally advanced head and neck squamous cell carcinomaYungan Tao, Keyvan Rezaï, Etienne Brain, et al.
Pageof 7